Specifically, a consistent negative correlation was observed between LANCL1 expression and ROS levels, as well as ROS-responsive gene expression, in hepatocellular carcinoma (HCC) cell lines [40]. The gene discussed is LANCL1; the disease is hepatocellular carcinoma.